Magnetar Financial’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Magnetar Financial’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-317,641	Closed	-$3.32M	–	706
2023 Q1	$3.32M	Hold	317,641	–	–	0.06%	211
2022 Q4	$3.27M	Hold	317,641	–	–	0.06%	314
2022 Q3	$3.19M	Buy	317,641 +179,800	+130%	+$1.8M	0.04%	463
2022 Q2	$1.39M	Buy	+137,841	New	+$1.37M	0.01%	852

Other funds holding BIOS

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Quarry LP New York $1.2B AUM 47.63% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Magnetar Financial's BIOS Position: Q2 2023 in Review

Magnetar Financial sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q2 2023, closing a stake of 317,641 shares — an estimated $3.32M sold.

Magnetar Financial first reported a position in BIOS in Q2 2022 and held it in 4 quarters. The position peaked at $3.32M in Q1 2023. 32 funds tracked by Wall St. Rank hold BIOS as of Q2 2023.

Magnetar Financial reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Magnetar Financial sold 317,641 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q2 2023, an estimated $3.32M.
Magnetar Financial first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q2 2022 and held it in 4 quarters.
Magnetar Financial's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $3.32M in Q1 2023.
32 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q2 2023.

Based on Magnetar Financial's 13F filing for Q2 2023, filed 11 Aug 2023.